Skip to content

Effects of Melothria maderaspatana (Titta kekiri) and Passiflora foetida (Dal batu) dry fruit preparation (topical application) on renal functions of Grade II and III Chronic Kidney Disease (of unknown etiology) patients in North central Province, Sri L

Effects of Melothria maderaspatana (Titta kekiri) and Passiflora foetida (Dal batu) dry fruit preparation (topical application) on renal functions of Grade II and III Chronic Kidney Disease (of unknown etiology) patients in North central Province, Sri Lan

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2011/005
Enrollment
35
Registered
2011-03-25
Start date
2011-04-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease (of unknown etiology)

Interventions

Paste of dried Melothria maderaspatana (Titta kekiri) and Passiflora foetida (Dal batu) will be applied for 6 hours daily to the big toe of test group for a period of 10 months. Placebo paste will be

Sponsors

Faculty of Medicine University of Rajarata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Diagnosed patients of having grade II and III CKDu, Normal HbA1C (?6.5%) and BP?160/100 mmHg untreated or ?140/90 mmHg on up to two antihypertensive agents, Persistent albuminuria + eGFR 30- 89 mi/min/1.73m2 b)Age between 20-60 years c)Permanent residents of Anuradhapura or Polonnaruwa district, for at least 5 years prior to diagnosis as Grade II or III CKDu

Exclusion criteria

Exclusion criteria: a)Patients with no past history of or current treatment for diabetes mellitus or chronic and/or severe hypertension, snakebite, urological disease of known etiology or glomerulonephritis b)Patients who are suffering with other chronic diseases or on treatment for any other disease other than CKDu c)Patients aged less than 20 years and more than 65 years d)Pregnant and breast feeding mothers e)Patients who live outside the NCP,are not permanent resident within NCP at least 5 years prior to diagnose as CKDu and residents in GN divisions where WHO is conducting the Study for CKDu

Design outcomes

Primary

MeasureTime frame
Full blood count [10 months] Lipid profile [10 months ] Renal profile [10 months ] Liver enzymes-SGPT and SGOT [10 months ] Urine full report including ß2 globulin level [10 months ] IFNd [10 months ] TNFa [10 months ] HSP70 [10 months ]

Secondary

MeasureTime frame
None [None]

Countries

Sri Lanka

Contacts

Public ContactDr. M.A.C.S.Jayasumana

Lecturer in Pharmacology

jayasumanalk@yahoo.com0252234464

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026